JAK2 and ovarian carcinoma: The IL-6/JAK2/STAT3 pathway has been shown to increase proliferation and migration of ovarian cancer cells, and ovarian cancer patient derived ascites cells (Kim et al., 2017), as well as the migration and invasion of breast cancer cells (Walter et al., 2009).